L. Thompson

发表

mRNA detection in living cells: A next generation cancer stem cell identification technique.

S. McClellan, M. Finan, J. Slamecka, 2015, Methods.

Vaccination for melanoma

C. Slingluff, L. Brinckerhoff, L. Thompson, 2000, Current oncology reports.

Melanoma vaccines.

C. Slingluff, L. Brinckerhoff, L. Thompson, 2000, Current opinion in oncology.

Identification of a shared epitope recognized by melanoma-specific, HLA-A3-restricted cytotoxic T lymphocytes.

J. Shabanowitz, D. Hunt, V. Engelhard, 2003, Immunology letters.

Preventing the Spontaneous Modification of an HLA-A2-Restricted Peptide at an N-Terminal Glutamine or an Internal Cysteine Residue Enhances Peptide Antigenicity

J. Shabanowitz, D. Hunt, V. Engelhard, 2004, Journal of immunotherapy.

Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens

D. Hunt, V. Engelhard, C. Slingluff, 2000, Cancer Immunology, Immunotherapy.

Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development.

J. Shabanowitz, D. Hunt, V. Engelhard, 1998, Journal of immunology.

Identification of Novel and Widely Expressed Cancer/Testis Gene Isoforms That Elicit Spontaneous Cytotoxic T-Lymphocyte Reactivity to Melanoma

J. Shabanowitz, D. Hunt, V. Engelhard, 2004, Cancer Research.

Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.

D. Hunt, C. Slingluff, G. Yamshchikov, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

This information is current as Melanoma Cell Responses in a Long-Term Survivor of Sequential Immune Escape and Shifting of T Ferrone

V. Engelhard, C. Slingluff, S. Ferrone, 2005 .

Terminal modifications inhibit proteolytic degradation of an immunogenic mart‐127–35 peptide: Implications for peptide vaccines

V. Engelhard, R. Pierce, C. Slingluff, 1999, International journal of cancer.

Sequential Immune Escape and Shifting of T Cell Responses in a Long-Term Survivor of Melanoma 1

V. Engelhard, C. Slingluff, S. Ferrone, 2005, The Journal of Immunology.

Competition Among Peptides in Melanoma Vaccines for Binding to MHC Molecules

V. Engelhard, R. Pierce, C. Slingluff, 2004, Journal of immunotherapy.